Minerva Neurosciences, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Minerva Neurosciences, Inc. reported Cash And Cash Equivalents At Carrying Value of $82.30 million for the year ending 2025.

  • Minerva Neurosciences, Inc. showed an increase of +285.3% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Minerva Neurosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 11, 2026.
  • XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 14 years of available data (2012 to 2025), Minerva Neurosciences, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 40,986.4%.
  • Historical annual values: Fiscal year 2025: $82.30 million | Fiscal year 2024: $21.36 million | Fiscal year 2023: $40.91 million | Fiscal year 2022: $36.09 million | Fiscal year 2021: $60.76 million | Fiscal year 2020: $25.36 million | Fiscal year 2019: $21.41 million | Fiscal year 2018: $50.23 million | Fiscal year 2017: $26.05 million | Fiscal year 2016: $82.98 million | Fiscal year 2015: $14.28 million | Fiscal year 2014: $18.55 million | Fiscal year 2013: $1.82 million | Fiscal year 2012: $200.3 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: